Acarix AB (DE:7AC)
FRANKFURT:7AC
Germany Market
Holding DE:7AC?
Track your performance easily

Acarix AB (7AC) Stock Price & Analysis

1 Followers

7AC Stock Chart & Stats


Financials

Annual

7AC FAQ

What was Acarix AB’s price range in the past 12 months?
Acarix AB lowest stock price was €0.01 and its highest was €0.05 in the past 12 months.
    What is Acarix AB’s market cap?
    Currently, no data Available
    When is Acarix AB’s upcoming earnings report date?
    Acarix AB’s upcoming earnings report date is Nov 07, 2024 which is in 30 days.
      How were Acarix AB’s earnings last quarter?
      Acarix AB released its earnings results on Aug 22, 2024. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of €0 by -€0.002.
        Is Acarix AB overvalued?
        According to Wall Street analysts Acarix AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Acarix AB pay dividends?
          Acarix AB does not currently pay dividends.
          What is Acarix AB’s EPS estimate?
          Acarix AB’s EPS estimate is €0.
            How many shares outstanding does Acarix AB have?
            Acarix AB has 973,170,170 shares outstanding.
              What happened to Acarix AB’s price movement after its last earnings report?
              Acarix AB reported an EPS of -€0.002 in its last earnings report, missing expectations of €0. Following the earnings report the stock price went down -33.333%.
                Which hedge fund is a major shareholder of Acarix AB?
                Currently, no hedge funds are holding shares in DE:7AC
                ---

                Acarix AB Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                56.25%
                12-Months-Change

                Fundamentals

                Return on Equity
                -123.59%
                Trailing 12-Months
                Asset Growth
                36.98%
                Trailing 12-Months

                Company Description

                Acarix AB

                Acarix AB operates as a medical technology company which is engaged in developing diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Its main activities are to develop, produce and market a new cardiovascular diagnostic method and similar equipment for the same and related services. The company develops the CADScor acoustic device that is designed to be used by doctors to help assess patients' risk of coronary artery disease.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                FinLab AG
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis